Somatomedin in Insulin-Dependent Diabetes Mellitus

Abstract

Somatomedin activity in sera from 12 insulin-dependent diabetics was measured by the chick embryo cartilage assay system. All patients required insulin for control of hyperglycemia and had been continuously treated with exogenous insulin for 3 to 25 yr. Mean fasting somatomedin activity was elevated in this group of diabetics and activity did not correlate with the simultaneous blood glucose concentrations. No significant differences were demonstrable between levels in diabetics with and without retinopathy or in patients with and without proteinuria.